Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study
Titel:
Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study
Auteur:
Tamura, Kenji Tsurutani, Junji Takahashi, Shunji Iwata, Hiroji Krop, Ian E Redfern, Charles Sagara, Yasuaki Doi, Toshihiko Park, Haeseong Murthy, Rashmi K Redman, Rebecca A Jikoh, Takahiro Lee, Caleb Sugihara, Masahiro Shahidi, Javad Yver, Antoine Modi, Shanu